8077
0
Posted on Feb 12, 2004, 11 a.m.
By Bill Freeman
SEATTLE POST-INTELLIGENCER NEWS SERVICES Decode Genetics, the Icelandic company that discovered genes for schizophrenia and osteoporosis, has found a variant gene that doubles the risk of heart attack and stroke among Icelanders who carry it, the company's researchers are reporting today. The company says it is starting advanced clinical trials of a drug intended to counteract the variant gene's effects.
SEATTLE POST-INTELLIGENCER NEWS SERVICES Decode Genetics, the Icelandic company that discovered genes for schizophrenia and osteoporosis, has found a variant gene that doubles the risk of heart attack and stroke among Icelanders who carry it, the company's researchers are reporting today. The company says it is starting advanced clinical trials of a drug intended to counteract the variant gene's effects. The company's chief executive, Dr. Kari Stefansson, says the drug could help more patients beyond those who carry the variant gene. Last year, more than a million people in the United States died of heart disease and stroke.
Source: http://seattlepi.nwsource.com/health/159852%5fmedi09.html
[Editor: The preceding article was not written by A4M/WHN]
